72 related articles for article (PubMed ID: 1849393)
1. [A case of small cell carcinoma of the lung responding well to oral etoposide therapy].
Nakaoka Y; Haraguchi M; Fujii T; Adachi N; Komatsu T; Ota K; Kurihara N
Gan To Kagaku Ryoho; 1991 Apr; 18(4):637-9. PubMed ID: 1849393
[TBL] [Abstract][Full Text] [Related]
2. [A case of remission of multiple retroperitoneal lymph node relapse in small cell lung cancer treated with oral etoposide].
Fujii S; Masakane I
Gan To Kagaku Ryoho; 1991 Feb; 18(2):297-300. PubMed ID: 1847031
[TBL] [Abstract][Full Text] [Related]
3. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
Mok TS; Wong H; Zee B; Yu KH; Leung TW; Lee TW; Yim A; Chan AT; Yeo W; Chak K; Johnson P
Cancer; 2002 Oct; 95(7):1511-9. PubMed ID: 12237920
[TBL] [Abstract][Full Text] [Related]
4. [An elderly case of small cell lung cancer showing a good partial response by chronic daily administration of oral etoposide].
Ishikawa S; Shimizu E; Kawaji K; Mukai J; Tani K; Okubo A; Ogura T; Sano T; Yamashita T
Gan To Kagaku Ryoho; 1991 Jan; 18(1):111-4. PubMed ID: 1846280
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
6. [A case of small cell lung cancer with renal insufficiency effectively treated with oral etoposide administration].
Akiyama Y; Kondo H; Kimura S; Fujii Y
Gan To Kagaku Ryoho; 1995 Apr; 22(5):683-6. PubMed ID: 7717722
[TBL] [Abstract][Full Text] [Related]
7. [Successful treatment of refractory extensive small cell lung cancer by oral etoposide].
Fujii S; Iwabuchi K
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1677-80. PubMed ID: 8060146
[TBL] [Abstract][Full Text] [Related]
8. [Effects of oral etoposide in small cell carcinoma of the lung].
Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Kawakami Y; Shimizu T; Onodera S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1244-7. PubMed ID: 6329103
[TBL] [Abstract][Full Text] [Related]
9. [A case of recurrent ovarian cancer markedly responding to daily oral administration of low dose etoposide].
Fujita H; Ito R; Yamamoto T; Okada H
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2261-4. PubMed ID: 2241191
[TBL] [Abstract][Full Text] [Related]
10. [Etoposide in the treatment of small-cell lung cancer].
Ueoka H
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1920-4. PubMed ID: 8978798
[TBL] [Abstract][Full Text] [Related]
11. [A phase II study of NK171 (etoposide)].
Kimura K; Niitani H
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
[TBL] [Abstract][Full Text] [Related]
12. [An elderly case of small cell lung cancer showing complete response by oral administration of etoposide].
Takigawa K; Amino Y; Wakana M; Kobayashi M; Asada Y; Nagai M; Fujita J; Irino S
Gan To Kagaku Ryoho; 1990 Jan; 17(1):141-5. PubMed ID: 2153368
[TBL] [Abstract][Full Text] [Related]
13. [A phase II study of etoposide (NK 171) in small cell lung cancer--comparison of results between intravenous administration and oral administration].
Furuse K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2352-7. PubMed ID: 3000299
[TBL] [Abstract][Full Text] [Related]
14. [A case of recurrent small cell lung cancer with symptoms improved by nogitecan hydrochloride].
Ueda H; Sano T; Bando H
Gan To Kagaku Ryoho; 2002 May; 29(5):795-8. PubMed ID: 12040688
[TBL] [Abstract][Full Text] [Related]
15. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic study and side effects of chronic daily administration of oral etoposide].
Taguchi O; Yamakami T; Machishi M; Gabazza EC; Ibata H; Tsutsui K; Suzuki S
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2005-9. PubMed ID: 1329670
[TBL] [Abstract][Full Text] [Related]
17. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
Kamath SS; McCarley DL; Zlotecki RA
Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Unsal M; Erturk D
Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
Miller AA; Rosner GL; Ratain MJ; Hollis DR; Green MR; Schilsky RL
Clin Cancer Res; 1997 May; 3(5):719-25. PubMed ID: 9815741
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.
Zucchetti M; Pagani O; Torri V; Sessa C; D'Incalci M; De Fusco M; de Jong J; Gentili D; Martinelli G; Tinazzi A
Clin Cancer Res; 1995 Dec; 1(12):1517-24. PubMed ID: 9815952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
